LFG
PLSE icon

Larson Financial Group’s Pulse Biosciences PLSE Stock Holding History

Larson Financial Group’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.96K Buy
137
+104
+315% +$1.92K ﹤0.01% 2838
2025
Q4 		$453 Sell
33
-149
-82% -$2.32K ﹤0.01% 3143
2025
Q3 		$3.22K Buy
+182
New +$2.88K ﹤0.01% 2519

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Larson Financial Group's PLSE Position: Q1 2026 in Review

Larson Financial Group increased its Pulse Biosciences (PLSE) stake by 315% in Q1 2026, buying an estimated $1.92K and bringing the position to 137 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #2838.

Larson Financial Group first reported a position in PLSE in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.22K in Q3 2025. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Larson Financial Group held 137 shares of Pulse Biosciences worth $2.96K as of Q1 2026.
  • Larson Financial Group bought 104 Pulse Biosciences shares in Q1 2026, an estimated $1.92K.
  • Pulse Biosciences made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2838 holding.
  • Larson Financial Group first reported a position in Pulse Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Larson Financial Group's Pulse Biosciences position peaked at $3.22K in Q3 2025.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.